If that is the case I would be worried that the US insurance companies will also be a hard sell.
I have been following AXP which also has a great product that really helps the patients, but they have really struggled to get surgeons to buy. I will keep an eye on AVH, but I think I want to see sales traction in the USA before buying in.
